Updated Jul 16, 2026
Plump Andrew Stewart has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Andrew Stewart Plump is a prominent executive in the pharmaceutical industry, currently serving as the President of Research and Development at Takeda Pharmaceutical Company Limited. He has a strong background in drug development and has contributed significantly to the advancement of various therapeutic areas within the company. Plump's leadership in R&D has been pivotal in driving innovation and enhancing the company's pipeline.
| Role | President, R&D, Director |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 125.4K | $0.00 | |
| 2026-04-28 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 212.5K | $0.00 |
Andrew Stewart Plump is a prominent executive in the pharmaceutical industry, currently serving as the President of Research and Development at Takeda Pharmaceutical Company Limited. He has a strong background in drug development and has contributed significantly to the advancement of various therapeutic areas within the company. Plump's leadership in R&D has been pivotal in dr…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Plump Andrew Stewart profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.